Could DexCom Be a Millionaire-Maker Stock?

07:04am, Thursday, 19'th Nov 2020
Probably not, but it'll still beat the market.
Biotech stocks simply can't match these reliable returns.

Better Buy: Abbott Laboratories vs. DexCom

08:39am, Tuesday, 17'th Nov 2020
These two companies are battling for market share of continuous glucose monitoring devices for diabetes, with each coming out with new models soon.

DexCom: The End Of The Beginning Is Almost Here

01:19pm, Saturday, 14'th Nov 2020
G7 could change the valuation dramatically. It is a risky play, especially in the short term.
Instead of investing in the company that would have made you a millionaire years ago, seek out the ones that have the potential from here.
With the disruption that the coronavirus caused us, the dependency on tech-based solutions makes these IoT stocks very relevant. The post 7 IoT Stocks That Are Banking on a Connected Future appeared f

Why DexCom Stock Crumbled in October

10:00am, Tuesday, 10'th Nov 2020
An analyst downgrade and marketwide turbulence weighed on the medical device maker's shares last month.

Why Is No One Talking About DexCom Stock?

05:06am, Saturday, 07'th Nov 2020
This medical device manufacturer has shown incredible momentum.
A Relative Strength Rating upgrade for Dexcom shows improving technical performance. The post Stock Upgrades: Dexcom Shows Rising Relative Strength appeared first on Investor's Business Daily.
IOT stocks represent companies on the cusp of a new paradigm where everyday objects connect to the internet. Here are seven that stand out.

Which Biotech Stocks Are a Buy on Earnings?

09:56am, Tuesday, 03'rd Nov 2020
If you're interested in high-growth biotech stocks with superior fundamentals, here are which ones to consider, and which ones to skip. The post Which Biotech Stocks Are a Buy on Earnings?

Dexcom to Host Investor Day on December 9, 2020

08:30am, Tuesday, 03'rd Nov 2020
SAN DIEGO--(BUSINESS WIRE)--Dexcom to Host Investor Day on December 9, 2020

How DexCom Trounced Wall Street Estimates in Q3

06:02am, Wednesday, 28'th Oct 2020
The diabetes care technology provider also again raised its full-year guidance.
DexCom, Inc. (DXCM) CEO Kevin Sayer on Q3 2020 Results - Earnings Call Transcript
Tech and telecom gains couldn't offset a bad day for other sectors.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE